Hypervascular benign and malignant liver tumors that require differentiation from hepatocellular carcinoma: key points of imaging diagnosis.
Hypervascular benign and malignant liver tumors that require differentiation from hepatocellular carcinoma: key points of imaging diagnosis.
复制标题
DOI：
10.1159/000343864
复制
发表时间：
2014-05
期刊：
影响因子：
13.8
通讯作者：
Tsurusaki M
中科院分区：
文献类型：
--
作者：
Murakami T;Tsurusaki M
大多数肝脏肿瘤是良性的和多血管的，避免对良性病变进行不必要的干预是很重要的。本文综述了常见的富血供肝脏良性肿瘤的典型和非典型影像学特征，并概述了鉴别肝脏良恶性病变的一般方法。有许多类型的良性肝脏肿瘤需要与肝细胞癌（HCC）相鉴别。因此，了解良性肿瘤的影像学特征是非常重要的。乙氧苄基二乙烯三胺五乙酸钆增强磁共振成像有助于诊断富血管假瘤、局灶性结节增生和与酒精性肝炎相关的结节性病变。还有一些富血管的恶性肿瘤，如胆管癌、胆管细胞癌、混合型肿瘤和转移性肝肿瘤，也需要与HCC鉴别。
Most liver tumors are benign and hypervascular, and it is important to avoid unnecessary interventions for benign lesions. This review describes the typical and atypical imaging features of common hypervascular benign liver tumors and outlines a general approach to distinguishing between benign and malignant hepatic lesions. There are many types of benign liver tumors that need to be differentiated from hepatocellular carcinoma (HCC). Therefore, it is very important to know the imaging characteristics of benign tumors. Gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging is helpful in diagnosing hypervascular pseudotumors, focal nodular hyperplasia, and nodular lesions associated with alcohol-induced hepatitis. There are also some hypervascular malignant tumors, such as cholangiocarcinoma, cholangiolocellular carcinoma, mixed type tumors, and metastatic liver tumors, which also required differentiation from HCC.
登录
查看更多内容
DOI：
10.1046/j.1440-1746.2003.03052.x
发表时间：
2003-06-01
影响因子：
4.1
作者：
An, HJ;Illei, P;Theise, N
通讯作者：
Theise, N
影响因子：
19.7
作者：
ITAI, Y;FURUI, S;TASAKA, A
通讯作者：
TASAKA, A
影响因子：
3.2
作者：
Kitajima, Kumiko;Shiba, Hiroaki;Yanaga, Katsuhiko
通讯作者：
Yanaga, Katsuhiko
影响因子：
3.4
作者：
Park, Jun Young;Choi, Moon Seok;Yoo, Byung Chul
通讯作者：
Yoo, Byung Chul
影响因子：
5.6
作者：
Nguyen, BN;Fléjou, JF;Degott, C
通讯作者：
Degott, C